GlassScriptPhysician profile
Ernest N Lo
NPI 1538482328
$14,253.70
in general payments reported to CMS, 2019-2025
75 companies · $1,838 in 2025
The $1,838 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,098 · 2020: $2,280 · 2021: $2,291 · 2022: $1,831 · 2023: $1,975 · 2024: $1,941 · 2025: $1,838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,754.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $888.22 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $843.20 | 2019-2025 | |
| Astellas Pharma US INC | $756.27 | 2019-2025 | Padcev, Xtandi |
| Astrazeneca Pharmaceuticals LP | $743.35 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $716.20 | 2019-2025 | Opdivo |
| Takeda Pharmaceuticals U.S.A., INC. | $695.33 | 2019-2025 | Fruzaqla, Ninlaro, Iclusig |
| Celgene Corporation | $668.89 | 2019-2025 | Reblozyl, Opdualag |
| Merck Sharp & Dohme LLC | $589.58 | 2019-2025 | Keytruda, Lynparza, Lenvima |
| Janssen Biotech, INC. | $565.16 | 2019-2025 | Rybrevant, Carvykti, Darzalex |
| Amgen INC. | $514.13 | 2019-2023 | Lumakras, Blincyto, Kyprolis |
| Pavmed INC. | $500.00 | 2022 | |
| Eisai INC. | $488.66 | 2019-2025 | |
| Seagen INC. | $444.26 | 2019-2023 | Tukysa |
| Genentech USA, INC. | $421.00 | 2019-2024 | Tecentriq, Alecensa, Polivy |
| Glaxosmithkline, LLC. | $404.69 | 2020-2025 | Ojjaara, Zejula, Jemperli |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $318.10 | 2019-2025 | Jaypirca, Verzenio |
| Array Biopharma INC | $312.11 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Puma Biotechnology, INC. | $234.09 | 2019-2025 | |
| Epizyme, INC. | $212.81 | 2020-2022 | |
| Exelixis INC. | $212.53 | 2019-2024 | Cabometyx |
| Genzyme Corporation | $202.37 | 2019-2023 | |
| Rigel Pharmaceuticals, INC. | $201.43 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Abbvie INC. | $183.19 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $177.70 | 2020-2025 | Libtayo |
| Emd Serono, INC. | $169.61 | 2021-2025 | Tepmetko |
| Alexion Pharmaceuticals, INC. | $168.24 | 2019-2025 | Ultomiris |
| Beigene USA, INC. | $167.39 | 2020-2024 | Brukinsa |
| Incyte Corporation | $150.21 | 2019-2023 | Jakafi |
| Pharmacyclics LLC, An Abbvie Company | $139.26 | 2019-2023 | Imbruvica |
| Bayer Healthcare Pharmaceuticals INC. | $131.87 | 2020-2025 | |
| Kite Pharma, INC. | $128.86 | 2020-2023 | Yescarta |
| Daiichi Sankyo INC. | $114.12 | 2019-2023 | Enhertu |
| Jazz Pharmaceuticals INC. | $113.58 | 2020-2025 | |
| Gilead Sciences, INC. | $105.79 | 2019-2023 | Trodelvy |
| Blueprint Medicines Corporation | $101.03 | 2020-2024 | Ayvakit |
| Taiho Oncology, INC. | $91.34 | 2020-2023 | |
| Kyowa Kirin, INC. | $75.90 | 2023-2025 | Poteligeo |
| Aveo Pharmaceuticals, INC. | $75.39 | 2021-2023 | Fotivda |
| Acrotech Biopharma INC. | $74.13 | 2021-2025 | Beleodaq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.74 | 2020-2022 | |
| Agios Pharmaceuticals, INC. | $70.15 | 2019-2025 | Pyrukynd |
| Acceleron Pharma, INC. | $68.62 | 2020-2021 | |
| Tersera Therapeutics LLC | $65.79 | 2019-2020 | |
| Deciphera Pharmaceuticals INC. | $65.50 | 2021-2024 | Qinlock |
| Pharmaessentia USA Corporation | $59.10 | 2022-2025 | Besremi |
| Ipsen Biopharmaceuticals, INC | $56.94 | 2019-2024 | Onivyde |
| Servier Pharmaceuticals LLC | $40.62 | 2021 | |
| Springworks Therapeutics, INC. | $39.97 | 2025 | Ogsiveo |
| Aurobindo Pharma USA, INC. | $32.54 | 2019-2020 | |
| Pharmacosmos Therapeutics INC. | $31.98 | 2024 | Monoferric |
| Invivyd INC | $30.57 | 2025 | Pemgarda |
| Sun Pharmaceutical Industries INC. | $30.48 | 2020-2023 | Odomzo, Yonsa |
| Octapharma USA, INC. | $30.00 | 2023 | Octagam Immune Globulin (Human) |
| Stemline Therapeutics INC. | $29.12 | 2023 | Orserdu |
| Immunocore Limited | $27.43 | 2025 | Kimmtrak |
| Sirtex Medical INC | $27.42 | 2020 | |
| Janssen Pharmaceuticals, INC | $26.05 | 2022 | |
| Tesaro, INC. | $24.75 | 2019 | |
| Sobi, INC | $24.53 | 2023 | |
| Apellis Pharmaceuticals, INC. | $23.66 | 2023 | Empaveli |
| Beone Medicines USA, INC. | $23.04 | 2025 | Brukinsa |
| Foundation Medicine, INC. | $21.99 | 2023 | |
| Fennec Pharmaceuticals, INC. | $20.85 | 2025 | Fyarro |
| Organon LLC | $20.77 | 2021 | |
| Cardinal Health 414 LLC | $20.14 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Lexicon Pharmaceuticals, INC. | $19.52 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.25 | 2020 | |
| Clovis Oncology, INC. | $19.11 | 2020 | |
| Verity Pharmaceuticals INC. | $18.95 | 2025 | Tlando |
| Dova Pharmaceuticals | $18.23 | 2020 | |
| Myovant Sciences INC. | $16.70 | 2021 | |
| Heron Therapeutics, INC. | $16.70 | 2023 | Sustol |
| Mirati Therapeutics, INC. | $14.94 | 2023 | Krazati |
| Novocure INC. | $13.51 | 2025 | Optune Lua (Novottf-200t) |
| Paratek Pharmaceuticals, INC. | $11.05 | 2020 |
Drugs and devices associated with these payments
Reblozyl $292Padcev $255Imfinzi $250Braftovi $244Keytruda $243Opdivo $233Tukysa $232Mektovi $208Lenvima $207Imbruvica $193Lorbrena $184Ibrance $162Rybrevant $158Xtandi $125Epkinly $114Kisqali $114Ojjaara $111Fruzaqla $103Ninlaro $103Bosulif $99.32Iclusig $99.09Tecentriq $93.87Libtayo $92.60Jaypirca $89.88Alecensa $89.57Lynparza $85.06Brukinsa $84.43Scemblix $84.36Pluvicto $83.72Sarclisa $81.45Jemperli $81.20Zejula $81.20Verzenio $80.17Poteligeo $75.90Calquence $70.72Xalkori $65.75Polivy $61.73Oxbryta $58.89Besponsa $58.33Comirnaty $57.45Carvykti $56.84Lonsurf $54.93Inqovi $54.93Fotivda $52.24Inlyta $51.45Tavalisse $48.31Rezlidhia $48.31Cabometyx $46.28Enhertu $46.05Ultomiris $45.77Beleodaq $45.16Jakafi $42.04Elrexfio $40.99Adcetris $40.99Lumakras $40.46Ogsiveo $39.97Vitrakvi $39.68Ziihera $39.63Darzalex $38.59Zepzelca $38.43Tagrisso $36.16Piqray $33.87Venclexta $33.09Promacta $33.04Monoferric $31.98Pemgarda $30.57Kadcyla $30.43Phesgo $30.43Perjeta $30.43Ayvakit $30.01Octagam Immune Globulin (Human) $30.00Welireg $29.55Elitek $29.32Orserdu $29.12Pyrukynd $28.86Mekinist $28.84Fabhalta $28.83Jevtana $27.44Kimmtrak $27.43Nerlynx $27.02Nubeqa $27.01Xofigo $27.01Besremi $26.74Kyprolis $26.21Blincyto $26.21Qinlock $26.04Gavreto $26.00Yescarta $25.00Onivyde $24.68Doptelet $24.53Empaveli $23.66Alunbrig $22.89Trodelvy $21.33Fyarro $20.85Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) $20.14Opdualag $19.64Tlando $18.95Stivarga $17.55Odomzo $17.13Yonsa $17.13
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Lo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.